
Metvio 25mg Tablet CR
Marketer
Salud Care India Pvt Ltd
Salt Composition
Metoprolol Succinate (25mg)
Overview Metvio 25mg Tablet CR
Cardiobeta 25mg Extended-Release Tablets are a beta-blocker medication used to manage hypertension, angina pectoris, and cardiac arrhythmias. This medication also aids in migraine prevention and reduces the risk of future strokes and myocardial infarctions. Cardiobeta 25mg ER may be administered independently or in conjunction with other therapies; dosage and frequency are individualized based on the specific condition and its severity. Administering the medication consistently at the same time each day, regardless of meals, optimizes therapeutic effects. Full benefits may take several weeks to manifest, and continuous use may be necessary. Discontinuing treatment can exacerbate underlying conditions; therefore, consistent use is crucial, even in the absence of symptoms. Common side effects, generally mild and transient, include fatigue, cephalalgia, dysphoria, diarrhea, dermatological reactions, bradycardia, dizziness, and nausea. Less frequently, hypotension or dyspnea may occur. Gradual dose escalation minimizes adverse effects. Consult your physician if side effects persist or are bothersome. Prior to initiating therapy, disclose any hepatic impairment to your physician. Cardiobeta 25mg ER is contraindicated in individuals with bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension. Pregnant or lactating women should seek medical counsel before commencing treatment. Individual suitability should be determined through consultation with a healthcare professional, and regular blood pressure monitoring is essential to gauge treatment efficacy. Alcohol consumption should be avoided due to the potential for exacerbated side effects.
Primary Ingredients of Metvio 25mg Tablet CR
No text provided. Please provide the text you wish me to rephrase.
Uses of Metvio 25mg Tablet CR
Managing angina pectoris (chest pain due to heart issues) | Addressing cardiac arrhythmias | Reducing the risk of myocardial infarction | Hypertension (high blood pressure) management | Migraine prophylaxis
Major Benefits of Metvio 25mg Tablet CR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Metvio 25mg Tablet CR. Ingest the tablet whole; do not crush, chew, or divide it. This medication can be taken with or without food, but consistency in timing is recommended. Minimize consumption of high-fat foods, including olive oil, nuts (especially Brazil nuts), dark chocolate, butter, and red meat, while taking Metvio 25mg Tablet CR.
Common Side effects of Metvio 25mg Tablet CR:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Metvio 25mg Tablet CR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Metvio 25mg Tablet CR can be consumed with or without food; however, consistent daily timing is recommended. High-fat foods, including olive oil, nuts (especially Brazil nuts), dark chocolate, butter, and meat, should be avoided when taking Metvio 25mg Tablet CR.
How Metvio 25mg Tablet CR works:
Cardiomet 25mg Extended-Release tablets are a sustained-release beta-adrenergic blocker with cardioselective activity. This medication reduces heart rate and enhances the heart's pumping efficiency, improving circulatory function.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Metvio 25mg Tablet CR ingestion is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Using Metvio 25mg CR tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Metvio 25mg tablets are likely safe for breastfeeding mothers. Available human data indicate minimal infant risk associated with the medication.
DrivingUNSAFE
Taking Metvio 25mg Tablet CR might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Metvio 25mg Tablet CR poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverCAUTION
Patients with hepatic impairment should use Metvio 25mg CR tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Metvio 25mg Tablet CR :
Should you forget to take a Metvio 25mg Tablet CR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metvio 25mg Tablet CR
| Label | Value |
|---|---|
| Chemical Classification | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | Heart |
